To The Moon

Disclaimer: This news brief was created by Public Technologies using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ST - Singapore Technologies Engineering Ltd. published the original content used to generate this news brief on February 04, 2026, and is solely responsible for the information contained therein.

Big tech stocks dropped in premarket trading and the dollar and bond yields shot up ​on Friday after U.S. President Donald Trump said he has firmed up his choice to lead the Federal Reserve, with...

Spot Gold Extends Declines, Last Down 4% at $5,167.69/Oz

Lockheed Martin forecast 2026 profit and revenue above Wall Street estimates on Thursday.

Lam Research forecasts strong quarterly results on chipmaking tool demand Jan 28 (Reuters) - Lam Research LRCX.O forecast third-quarter revenue above Wall Street expectations on Wednesday, as enterpri

Wall Street is delivering a contradictory verdict on Tesla.

$Richtech Robotics(RR)$, a U.S.-based provider of AI-driven robots operating in commercial and industrial environments, today announced a hands-on collaboration with $Microsoft(MSFT)$ through the...

$Richtech Robotics(RR)$, a U.S.-based provider of AI-driven robots operating in commercial and industrial environments, today announced a hands-on collaboration with $Microsoft(MSFT)$ through the...

ImmunityBio, Inc. recently presented at the Jefferies London Healthcare Conference 2025, sharing updates on its latest performance and product developments at the ME Hotel in London. A noteworthy highlight was the company’s significant third-quarter product revenue growth, driven by strong commercial demand for Anktiva in combination with BCG for BCG-unresponsive NMIBC with CIS. We’ll explore how robust Anktiva product uptake and higher revenue impact ImmunityBio’s investment narrative and...